Emergence of and risk factors for ciprofloxacin-gentamicin-resistant Escherichia coli urinary tract infections in a region of Quebec

scientific article

Emergence of and risk factors for ciprofloxacin-gentamicin-resistant Escherichia coli urinary tract infections in a region of Quebec is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1155/2009/971624
P932PMC publication ID2807251
P698PubMed publication ID21119795

P2093author name stringJacques Pépin
Caroline Lacroix
Isabelle Alarie
Mireille Plamondon
P2860cites workMacrolide resistance in bacteremic pneumococcal disease: implications for patient management.Q50723526
Community-onset urinary tract infections: a population-based assessment.Q51102559
Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia.Q54437579
Increasing resistance to antimicrobial agents of Gram-negative organisms isolated at a London teaching hospital, 1995-2000.Q54509427
Antibiotic Resistance and PyelonephritisQ58484042
Class I integrons in Gram-negative isolates from different European hospitals and association with decreased susceptibility to multiple antibiotic compoundsQ74533257
Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portuguese ICU Study GroupsQ77805594
A new method of classifying prognostic comorbidity in longitudinal studies: development and validationQ29547376
Integrating Escherichia coli antimicrobial susceptibility data from multiple surveillance programsQ30992335
Antimicrobial resistance trends and outbreak frequency in United States hospitalsQ33196006
Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA).Q33789579
Emergence and dissemination of quinolone-resistant Escherichia coli in the communityQ33978075
Emergence of reduced susceptibility and resistance to fluoroquinolones in Escherichia coli in Taiwan and contributions of distinct selective pressuresQ33983331
National nosocomial infections surveillance system (NNIS): Description of surveillance methodsQ34011924
Mechanisms of action and resistance of older and newer fluoroquinolonesQ34030757
Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United StatesQ34110686
An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS ProjectQ34166158
Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use.Q34177418
Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adultsQ34394950
The worldwide emergence of plasmid-mediated quinolone resistanceQ34569740
Population-based epidemiologic analysis of acute pyelonephritisQ34643113
Treatment of uncomplicated urinary tract infections in an era of increasing antimicrobial resistanceQ35858947
Antimicrobial-resistant invasive Escherichia coli, SpainQ35872947
Community-acquired antibiotic resistance in urinary isolates from adult women in CanadaQ36171292
Ambler class A extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. in Canadian hospitalsQ37119956
Trends in antimicrobial susceptibilities among Enterobacteriaceae isolated from hospitalized patients in the United States from 1998 to 2001.Q39746439
Surveillance of bacterial resistance among isolates in Shanghai in 1999.Q43676002
Quinolone resistance among Escherichia coli strains from community-acquired urinary tract infections in GreeceQ44714032
Longitudinal trends in fluoroquinolone resistance among Enterobacteriaceae isolates from inpatients and outpatients, 1989-2000: differences in the emergence and epidemiology of resistance across organismsQ44778107
Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in TaiwanQ46798610
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferaseQ46862305
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectEscherichia coliQ25419
urinary tract infectionQ221668
gentamicinQ422482
P304page(s)e163-8
P577publication date2009-01-01
P1433published inCanadian Journal of Infectious Diseases & Medical MicrobiologyQ5030243
P1476titleEmergence of and risk factors for ciprofloxacin-gentamicin-resistant Escherichia coli urinary tract infections in a region of Quebec
P478volume20

Reverse relations

Q35644344Epidemiology and characteristics of urinary tract infections in children and adolescents.cites workP2860

Search more.